|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 31/4439 | (2006.01) | ||
| A61K 31/198 | (2006.01) | ||
| A61K 31/573 | (2006.01) | ||
| A61K 31/69 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 9/10 | (2006.01) | ||
| A61K 47/12 | (2006.01) | ||
| A61K 47/20 | (2006.01) | ||
| A61K 47/22 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3827845 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20215879.6 |
| Date of filing the European patent application | 2016-11-01 | |
| (97) | Date of publication of the European application | 2021-06-02 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-30 |
| (46) | Date of publication of the claims translation | 2022-06-10 |
| (30) | Number | Date | Country code |
| 201562250016 P | 2015-11-03 | US |
| (72) |
JANSSON, Richard , US
KUMAR, Vineet , US
|
| (73) |
Janssen Biotech, Inc. ,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Poodinės anti-CD38 antikūnų kompozicijos ir jų naudojimas |
| SUBCUTANEOUS FORMULATIONS OF ANTI-CD38 ANTIBODIES AND THEIR USES |
| Payment date | Validity (years) | Amount | |
| 2025-10-03 | 10 | 231.00 EUR |
| 2026-11-01 |